NDC product
Bronchial Cough Therapy
NDC 17312-018 · TRP Company
Key facts
| Product NDC | 17312-018 |
|---|---|
| Proprietary name | Bronchial Cough Therapy |
| Nonproprietary name | ANTIMONY POTASSIUM TARTRATE - PROTORTONIA CACTI - DROSERA ROTUNDIFOLIA - ECHINACEA, UNSPECIFIED - CALCIUM SULFIDE - HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED - SPONGIA OFFICINALIS SKELETON, ROASTED - |
| Substances | SPONGIA OFFICINALIS SKELETON, ROASTED, ANTIMONY POTASSIUM TARTRATE, PROTORTONIA CACTI, DROSERA ROTUNDIFOLIA, ECHINACEA, UNSPECIFIED, CALCIUM SULFIDE, HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Labeler | TRP Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Marketing start | Dec 1, 2011 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: